You are here

  • Home
  • Archive
  • Volume 75, Issue 6
  • Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

Authors

  • Marc Corbera-Bellalta Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ester Planas-Rigol Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ester Lozano Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Nekane Terrades-García Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Marco A Alba Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Sergio Prieto-González Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ana García-Martínez Department of Emergency Medicine, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Robert Albero Hematopathology Section, Department of Anatomic Pathology, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Anna Enjuanes Genomics and Haematopathology Unit, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Georgina Espígol-Frigolé Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • José Hernández-Rodríguez Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Pascale Roux-Lombard Division of Immunology and Allergy, University Hospital and Medical School, University of Geneva, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Walter G Ferlin Novimmune, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Jean-Michel Dayer Medical School, University of Geneva, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Marie H Kosco-Vilbois Division of Immunology and Allergy, University Hospital and Medical School, University of Geneva, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Maria C Cid Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Maria C Cid, Department of Autoimmune Diseases, Hospital Clínic, Villarroel 170, Barcelona 08036, Spain; mccid{at}clinic.ub.es
View Full Text

Citation

Corbera-Bellalta M, Planas-Rigol E, Lozano E, et al
Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis
Annals of the Rheumatic Diseases 2016;75:1177-1186.

Publication history

  • Received August 4, 2015
  • Revised October 26, 2015
  • Accepted November 6, 2015
  • First published December 23, 2015.
Online issue publication 
October 31, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/